Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Growth in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 4,500 shares, an increase of 28.6% from the February 28th total of 3,500 shares. Based on an average trading volume of 24,900 shares, the short-interest ratio is presently 0.2 days.

Apollomics Trading Down 7.1 %

NASDAQ APLMW opened at $0.01 on Tuesday. The firm has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.03.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.